Global Alzheimers Platform Foundation Inc

Global Alzheimer’s Platform Foundation

A non-profit organization building a unique network of researchers, volunteers, & communities focused on advancing Alzheimer’s and Parkinson's disease research. A non-profit organization building a unique network of researchers, volunteers, and communities focused on a single goal: advancing Alzheimer’s and Parkinson's research. GLOBAL ALZHEIMER'S PLATFORM FOUNDATION (GAP) WORKS WITH INTERNATIONAL ORGANIZATIONS THAT SHARE OUR GOALS FOR CLINICAL TRIAL INNOVATION. GAP REGULARLY ENGAGES WITH GLOBAL PARTNERS TO COORDINATE EFFORTS, SHARE INFORMATION AND MAINTAIN OPEN DIALOGUE WITH INITIATIVES UNDER DEVELOPMENT IN A NUMBER OF COUNTRIES AND CONTINENTS.
473290570
IČO
2015
Založeno
Washington, DC 20005 United States
Adresa
globalalzplatform.org
Web
GAP_Foundation
Twitter (1790)
GlobalALZPlatform
Facebook (1100)

Novinky

Poslední komentáře

Absolutely inspired by the amazing work the Global Alzheimer’s Platform Foundation is doing! Together, we can support groundbreaking research and ensure that everyone has access to the treatments they need. 💙 #EndAlzheimers
detail
So proud to see GAP leading the charge for diversity and inclusion in Alzheimer’s and Parkinson’s research! Let’s keep pushing for a brighter future for all those affected. 🌍✨ #TogetherForACure
detail

Poslední diskuze

1. How can we further engage underrepresented communities in clinical trials for Alzheimer's and Parkinson's research to ensure diversity and inclusivity?
Odpovědí: 3, Naposledy před 1 den detail
2. What innovative strategies could be implemented to lower the cost and duration of clinical trials while maintaining high quality in Alzheimer's and Parkinson's disease research?
Odpovědí: 3, Naposledy před 1 den detail

V okolí

Kontaktovat
Global Alzheimers Platform Foundation Inc logo
Global Alzheimers Platform Foundation Inc
+ Sledovat
44
Employee
4.5
Reviews
Washington
Místo
O společnosti

- G02 -

First of its kind Alzheimers Head to Head Study Comparing Leading Biomarkers Closes Unprecedented participation from underrepresented communities Menu Speeding up the delivery of Alzheimers Parkinsons Disease Treatments GAP and our over 100 clinical research partners GAPNet Sites around the world are collaborating to speed the delivery of Alzheimers and Parkinsons disease treatments with a commitment to promoting diversity in clinical research as well as lowering the cost and duration of clinical trials to ensure that no one is left behind. Nearly 7 Million Americans are currently living with Alzheimers disease. 141 Increase in deaths from Alzheimers between 2000 and 2021. 360 Billion The estimated cost of treating Alzheimers in the United States in 2024.

Správa a technická pomoc.
23 Vacancy More Detail